Classifying "recurrent" breast cancer: Lost heterozygosity found

American Journal of Clinical Pathology

Volumn 123, Issue 5, 2005, Pages 641-643

  Hameed, Omar ^a   Pfeifer, John D ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER CLASSIFICATION; CANCER RECURRENCE; EDITORIAL; EVALUATION; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MICROSATELLITE INSTABILITY; MOLECULAR BIOLOGY; MOLECULAR GENETICS; PRIORITY JOURNAL; RECURRENT CANCER; SECOND CANCER;

EID: 17844407923     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/1LUB3K7R6VPHV4WW     Document Type: Editorial

References (19)

1. Goldstein NS, Kestin L, Vicini F. Factors associated with ipsilateral breast failure and distant metastases in patients with invasive breast carcinoma treated with breast-conserving therapy: a clinicopathologic study of 607 neoplasms from 583 patients. Am J Clin Pathol. 2003;120:500-527.
2. Haffty BG, Reiss M, Beinfield M, et al. Ipsilateral breast tumor recurrence as a predictor of distant disease: implications for systemic therapy at the time of local relapse. J Clin Oncol. 1996;14:52-57.
3. Veronesi U, Marubini E, Del Vecchio M, et al. Local recurrences and distant metastases after conservative breast cancer treatments: partly independent events. J Natl Cancer Inst. 1995;87:19-27.
4. Elkhuizen PH, van de Vijver MJ, Hermans J, et al. Local recurrence after breast-conserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys. 1998;40:859-867.
5. Huang E, Buchholz TA, Meric F, et al. Classifying local disease recurrences after breast conservation therapy based on location and histology: new primary tumors have more favorable outcomes than true local disease recurrences. Cancer. 2002;95:2059-2067.
6. Smith TE, Lee D, Turner BC, et al. True recurrence vs new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys. 2000;48:1281-1289.
7. Fredriksson I, Liljegren G, Amesson LG, et al. Local recurrence in the breast after conservative surgery; a study of prognosis and prognostic factors in 391 women. Eur J Cancer. 2002;38:1860-1870.
8. Goldstein NS, Vicini FA, Hunter S, et al. Molecular clonality determination of ipsilateral recurrence of invasive breast carcinomas after breast-conserving therapy: comparison with clinical and biologic factors. Am J Clin Pathol. 2005;123:679-689.
9. Brinkmann D, Ryan A, Ayhan A, et al. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. J Natl Cancer Inst. 2004;96:1441-1446.
10. Noguchi S, Motomura K, Inaji H, et al. Differentiation of primary and secondary breast cancer with clonal analysis. Surgery. 1994;115:458-462.
11. Janschek E, Kandioler-Eckersberger D, Ludwig C, et al. Contralateral breast cancer: molecular differentiation between metastasis and second primary cancer. Breast Cancer Res Treat. 2001;67:1-8.
12. Unger MA, Rishi M, Clemmer VB, et al. Characterization of adjacent breast tumors using oligonucleotide microarrays. Breast Cancer Res. 2001;3:336-341.
13. Sieben NL, Kolkman-Uljee SM, Flanagan AM, et al. Molecular genetic evidence for monoclonal origin of bilateral ovarian serous borderline tumors. Am J Pathol. 2003;162:1095-1101.
14. Nakayama T, Taback B, Turner R, et al. Molecular clonality of intransit melanoma metastasis. Am J Pathol. 2001;158:1371-1378.
15. Huang J, Behrens C, Wistuba I, et al. Molecular analysis of synchronous and metachronous tumors of the lung: impact on management and prognosis. Ann Diagn Pathol. 2001;5:321-329.
16. Altimari A, Gruppioni E, Fiorentino M, et al. Genomic allelotyping for distinction of recurrent and de novo hepatocellular carcinoma after orthotopic liver transplantation. Diagn Mol Pathol. 2005;14:34-38.
17. Regitnig P, Moser R, Thaihammer M, et al. Microsatellite analysis of breast carcinoma and corresponding local recurrences. J Pathol. 2002;198:190-197.
18. Amari M, Moriya T, Ishida T, et al. Loss of heterozygosity analyses of asynchronous lesions of ductal carcinoma in situ and invasive ductal carcinoma of the human breast. Jpn J Clin Oncol. 2003;33:556-562.
19. Schlechter BL, Yang Q, Larson PS, et al. Quantitative DNA fingerprinting may distinguish new primary breast cancer from disease recurrence. J Clin Oncol 2004;22:1830-1838.